Motility‐related protein‐1/CD9 expression in head and neck squamous cell carcinoma
- 2 September 2003
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 25 (10) , 848-857
- https://doi.org/10.1002/hed.10306
Abstract
Introduction. Motility-related protein (MRP)-1/CD9 is implicated in cell adhesion and motility and was shown to be clearly involved in tumor prognosis and angiogenesis. Elevated MRP-1/CD9 expression on tumor cells has been linked to a favorable prognosis in breast cancer, colon cancer, lung cancer, and HNSCC. Because MRP-1/CD9 is associated with angiogenesis, it might play a role in tumor angiogenesis as well. Methods. We analyzed MRP-1/CD9 expression in HNSCC specimens and cell lines by real-time RT-PCR and in HNSCC biopsy specimens and stromal vessels by immunohistochemistry. Kruskal Wallis and X2 test, univariate and multivariate Cox regression, and Kaplan-Meier methods were used for statistical analysis. Results. Real-time and PCR RT showed elevated expression of MRP-1/CD9 in one (SCC25) of four HNSCC cell lines and two of six HNSCC patients, whereas two cell lines (SCC9 and JPPA) and one HNSCC patient had lower MRP-1/CD9 levels compared with other specimens. Immunohistochemistry demonstrated strong MRP-1/CD9 IR expression on tumor cells in 13 patients (39%), whereas 21 patients (61%) had less to medium MRP-1/CD9 IR expression. Increased MRP-1/CD9 expression on tumor cells was correlated with prolonged patient survival (p = .02) and a longer disease-free interval (p = .004), a diminished recurrence rate (p = .02), and lower stages of neck lymph nodes (p = .04). MRP-1/CD9 IR was also found in a subpopulation of vessels that seem to be less in tumor specimens than in normal mucosa (p < .0001). MRP-1/CD9+ vessels are podoplanin+ and are therefore regarded as lymphatic vessels. Conclusions. Our results revealed that elevated MRP-1/CD9 expression on HNSCC is linked to a favorable clinical outcome and confirmed reports of MRP-1/CD9 expression in other carcinomas. MRP-1/CD9+ vessels were found to be lymphatic in nature. The number and staining intensity of these vessels is decreased in tumor tissue, which suggests a stabilizing role for this protein in lymphangiogenesis. © 2003 Wiley Periodicals, Inc. Head Neck 25: 848–857, 2003Keywords
This publication has 32 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Localization of CD9, an Enhancer Protein for Proheparin-Binding Epidermal Growth Factor–Like Growth Factor, in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinomaBritish Journal of Cancer, 1999
- Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with α3β1 integrinBritish Journal of Dermatology, 1997
- CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA‐DR and VLA integrinsEuropean Journal of Immunology, 1996
- Association of TM4SF proteins with integrins: relevance to cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- CD63 Associates with Transmembrane 4 Superfamily Members, CD9 and CD81, and with β1 Integrins in Human MelanomaBiochemical and Biophysical Research Communications, 1996
- A Tetraspan Membrane Glycoprotein Produced in the Human Intestinal Epithelium and Liver That Can Regulate Cell Density-dependent ProliferationJournal of Biological Chemistry, 1995
- Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanomaInternational Journal of Cancer, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958